Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec;37(12):1735-1744.
doi: 10.1007/s12264-021-00749-x. Epub 2021 Jul 27.

Hot Topics in Recent Parkinson's Disease Research: Where We are and Where We Should Go

Song Li #  1   2 , Congcong Jia #  1   2 , Tianbai Li  1   2 , Weidong Le  3   4   5
Affiliations
Review

Hot Topics in Recent Parkinson's Disease Research: Where We are and Where We Should Go

Song Li et al. Neurosci Bull. 2021 Dec.

Abstract

Parkinson's disease (PD), the second most common neurodegenerative disease, is clinically characterized by both motor and non-motor symptoms. Although overall great achievements have been made in elucidating the etiology and pathogenesis of PD, the exact mechanisms of this complicated systemic disease are still far from being clearly understood. Consequently, most of the currently-used diagnostic tools and therapeutic options for PD are symptomatic. In this perspective review, we highlight the hot topics in recent PD research for both clinicians and researchers. Some of these hot topics, such as sleep disorders and gut symptoms, have been neglected but are currently emphasized due to their close association with PD. Following these research directions in future PD research may help understand the nature of the disease and facilitate the discovery of new strategies for the diagnosis and therapy of PD.

Keywords: Biomarkers; Ferroptosis; Genetics; Gut-brain axis; Neuroinflammation; Parkinson’s disease; Sleep disorder.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Hot topics in recent Parkinson’s disease research.
See this image and copyright information in PMC

References

    1. Miyasaki JM, Shannon K, Voon V, Ravina B, Kleiner-Fisman G, Anderson K, et al. Practice Parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2006;66:996–1002. - PubMed
    1. de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol. 2006;5:525–535. - PubMed
    1. Armstrong MJ, Okun MS. Diagnosis and treatment of parkinson disease: a review. JAMA. 2020;323:548–560. - PubMed
    1. Lajoie AC, Lafontaine AL, Kaminska M. The spectrum of sleep disorders in parkinson disease: a review. Chest. 2021;159:818–827. - PubMed
    1. Elkouzi A, Vedam-Mai V, Eisinger RS, Okun MS. Emerging therapies in Parkinson disease—repurposed drugs and new approaches. Nat Rev Neurol. 2019;15:204–223. - PMC - PubMed

MeSH terms